Leukocyte counts and lymphocyte subsets in relation to pregnancy and HIV infection in Malawian women by Mandala, Wilson et al.
Am J Reprod Immunol. 2017;78:e12678. wileyonlinelibrary.com/journal/aji | 1 of 7
https://doi.org/10.1111/aji.12678
Received:24August2016  |  Accepted:27February2017
DOI: 10.1111/aji.12678
O R I G I N A L  A R T I C L E
Leukocyte counts and lymphocyte subsets in relation to 
pregnancy and HIV infection in Malawian women
Wilson L. Mandala1,2,3  | Esther N. Gondwe1,3 | Malcolm E. Molyneux1,3 |  
Jenny M. MacLennan1,4 | Calman A. MacLennan1,5,6
1Malawi-Liverpool Wellcome Trust Clinical 
Research Programme, College of Medicine, 
Blantyre, Malawi
2Department of Basic Medical 
Sciences, College of Medicine, Blantyre, 
Malawi
3Liverpool School of Tropical Medicine, 
Liverpool, UK
4Department of Zoology, University of Oxford, 
Oxford, UK
5The Jenner Institute, Nuffield Department of 
Medicine, University of Oxford, Oxford, UK
6Institute of Immunology and 
Immunotherapy, College of Medicine and 
Dental Sciences, University of Birmingham, 
Birmingham, UK
Correspondence
Wilson L. Mandala, Malawi-Liverpool 
Wellcome Trust Clinical Research Programme, 
College of Medicine, Blantyre, Malawi.
Email: wmandala2002@gmail.com
Funding information 
This work was supported by a PhD 
studentship from the Gates Malaria 
Partnership (to WLM) which received support 
fromtheBillandMelindaGatesFoundation,
aWellcomeTrustResearchFellowship(to
C.A.M.), a Wellcome Trust Programme Grant 
(toM.E.M.),andaClinicalResearchFellowship
from GlaxoSmithKline (to C.A.M)
Problem: We investigated leukocyte and lymphocyte subsets in HIV- infected or HIV- 
uninfected, pregnant or non- pregnant Malawian women to explore whether HIV in-
fection and pregnancy may act synergistically to impair cellular immunity.
Method of study: We recruited 54 pregnant and 48 non- pregnant HIV- uninfected 
women and 24 pregnant and 20 non- pregnant HIV- infected Malawian women. We 
compared peripheral blood leukocyte and lymphocyte subsets between women in the 
four groups.
Results: Parturient HIV- infected and HIV- uninfected women had more neutrophils 
(each P<.0001), but fewer lymphocytes (P<.0001; P=.0014) than non- pregnant 
women. Both groups had fewer total T cells (P<.0001; P=.002) and CD8+ T cells 
(P<.0001; P=.014) than non- pregnant women. HIV- uninfected parturient women had 
fewer CD4+ and γδ T cells, B and NK cells (each P<.0001) than non- pregnant women. 
Lymphocyte subset percentages were not affected by pregnancy.
Conclusion: Malawian women at parturition have an increased total white cell count 
due to neutrophilia and an HIV- unrelated pan- lymphopenia.
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1  | INTRODUCTION
In the Global Burden of Disease 2010 study, 254 700 deaths were at-
tributed to maternal conditions, accounting for 7.3% of global deaths 
in women aged 15 to 49 years. Of these, 21 900 were estimated to be 
due to maternal sepsis1 and recent reports indicate that as many as 
11% of global maternal mortality is due to sepsis.2 A focused analysis 
of maternal deaths in 2011 estimated that 99% (270 772/273 465) 
occurred in the developing world with 52% in sub- Saharan Africa.3 
Millennium Development Goal number 5 was aimed at lowering the 
maternal mortality ratio (MMR), the number of maternal deaths per 
100 000 live births, by three- quarters from 1990 to 2015,4 yet, as of 
2015, only 20 countries had achieved or were regarded to be on track 
to achieving this goal.2
There has been a growing appreciation of the impact of the 
HIV epidemic in hindering progress towards achieving Millennium 
DevelopmentGoal number 5. From 1980 to 1990, globalmaternal
mortality was decreasing by 1.8% per year. With the escalation of 
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the HIV/AIDS pandemic since the early 1990s, this decline slowed to 
1.4% per year for the period 1990- 2008.2 From1990 to2000, the
maternal mortality ratio (MMR) increased in many countries in sub- 
Saharan Africa with large HIV burdens; in Malawi, the reported MMR 
doubled in that decade from 606 to 1397 per 100 000 live births.3 
With the implementation of antiretroviral programmes, this trend has 
been reversed, and in 2011, the MMR in Malawi had fallen to 422.3 
Nevertheless, despite availability of ART, 20.5% (56 100) of maternal 
deaths worldwide in 2010 were HIV- related.1
In South Africa, nationwide confidential enquiries into facility- 
based deaths among pregnant women found that the MMR was 
almost 10- fold higher among HIV- infected women (328/100 000) 
than non- infected women (34/100 000).5 A key question pertains 
to the underlying cause of these HIV- related maternal deaths. 
Sepsis and other infections secondary to compromised immunity 
could be responsible.6 In the South African series, 53% (2102/3959) 
of  maternal deaths were due to infection, with 28% of these at-
tributed to pregnancy- related sepsis, often post- partum, and 72% 
to  non- pregnancy- related infections such as pneumonia and tuber-
culosis. Overall, 90% of the pregnancy- related sepsis and 96% of 
those non- pregnancy- related infections occurred in HIV- infected 
individuals.5
Pregnancy itself is a well- recognized cause of altered immunity, 
particularly cellular immunity7 affecting CD4+ T lymphocytes,8 the 
same cells that are targeted by HIV. We therefore hypothesized that 
HIV infection and pregnancy may act synergistically to impair cellular 
immunity, reducing CD4 counts and potentially increasing suscepti-
bility to infection. To explore this possibility among African women, 
we performed a prospective cross- sectional study of HIV- infected 
and HIV- uninfected pregnant and non- pregnant Malawians attending 
a health centre in Blantyre and compared leukocyte and lymphocyte 
subsets at parturition with those in non- pregnant women.
2  | MATERIALS AND METHODS
2.1 | Study area and population
We recruited pregnant and non- pregnant women between 26 
September 2006 and 15 January 2007 from Ndirande Health Centre 
(NHC) in Blantyre, Malawi, as they attended routine health checks or 
came for antenatal clinics. Informed consent was obtained from each 
participant. Exclusion criteria were presence of active disease and/
or fever and receiving medication at the time of recruitment. Blood 
samples were tested for HIV infection and malaria parasitaemia. Data 
from participants diagnosed with malaria were excluded from final 
statistical analysis. A 5- mL venous blood aliquot was taken from each 
participant, on the day of delivery from parturient women or on the 
day of recruitment from non- pregnant women. Seven of the 20 HIV- 
infected non- pregnant women were aged between 60 and 68, which 
is above the child- bearing age and were included in the analysis to 
increase the sample size for this group. All HIV- infected non- pregnant 
women were not aware of their HIV status prior to being recruited 
into the study, and thus, none were receiving HAART. However, all 
HIV- infected parturient women were taking nevirapine for different 
durations during their pregnancies.
2.2 | Investigations
HIV testing was performed using two rapid test kits; Determine 
(Abbott Laboratories, Japan) and Unigold (Trinity Brotch, Dublin). 
Thick and thin blood smears on slides were prepared by stand-
ard methods for Plasmodium falciparum parasite detection. Total white 
cell count (WCC) and percentages and absolute counts of neutro-
phils,  lymphocytes and monocytes were  determined using a HMX 
Haematological Analyser (Coulter, USA).
2.3 | Immunophenotyping
Immunophenotyping of blood samples by flow cytometry and 
 lymphocyte subset identification was performed according to Table 
S1. In brief, 25 μL of EDTA blood was mixed with 1 μL of each anti-
body and incubated in the dark at room  temperature for 15  minutes. 
About 500 μLof1×FACS lysing solution (BectonDickinson)was
added to each tube and incubated in the dark for 10 minutes to 
lyse erythrocytes. Cells were washed twice with PBS and fixed with 
1%formaldehyde(Sigma)/PBSanddataacquiredonaFACSCalibur
FlowCytometer.CellQuestwasusedforanalysisusingthegating
strategyinFig.S5.
2.4 | Ethical approval
Ethical approval for this study was obtained from College of Medicine 
Research and Ethics Committee (COMREC) in Blantyre, Malawi.
2.5 | Statistical analysis
Participants were grouped according to their pregnancy and HIV 
status. The median and range were determined for age and abso-
lute and percentage leukocyte and lymphocyte subset proportion in 
each group and are reported in the table. 10th and 90th percentiles 
weredeterminedforuseintheFigures.TheKruskal-Wallisequality-
of- populations rank test was used to identify overall differences be-
tween groups for each subset. Pairwise differences between two 
groups were then determined using the two- sample Wilcoxon rank- 
sum (Mann- Whitney) test. A P value of <.05 was considered statisti-
cally significant at 95% level of confidence. All statistical analyses 
were performed using Stata version 14 (StataCorp 2015).
3  | RESULTS
3.1 | Participants and global interaction of HIV and 
Pregnancy
We recruited 54 pregnant (median age 25 years [range: 17- 39]) and 
48 non- pregnant HIV- uninfected women (median age: 22 [17- 31]) 
and 24 HIV- infected pregnant women (median age: 25 [18- 37]) and 
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20 HIV- infected non- pregnant women (median age: 29 [18- 68]). 
Results of the global statistical analysis showed that with the ex-
ception of absolute monocyte counts and percentage of NK and γδ 
T cells, all other cell subsets were significantly different between 
groups (Table 1).
3.2 | Among non- pregnant women, HIV- infected 
individuals have lower mean WCC, neutrophil and 
CD4+ cell counts and a higher mean CD8+ cell count 
than HIV- uninfected individuals
To confirm the differences attributable to infection with HIV 
among Malawian women of child- bearing age, we compared  leukocyte 
and lymphocyte subset counts between HIV- infected and HIV- 
uninfected non- pregnant Malawian women. Total WCC (P=.004), 
neutrophil counts (P<.001) (Table1 andFig.S1A) andCD4+ T- cell 
counts (Fig. S1C) andpercentages (Fig. S1D) (bothP<.0001) were 
lower in HIV- infected than HIV- uninfected women, while CD8+ T- 
cell counts (P=.002)(Fig.S1C)andpercentages(P<.001)(Fig.S1D)
and neutrophil percentages of total white cells (P=.014) (Fig.S1B,
Table 1) were higher. B, NK and γδ T- cell counts were also lower in 
theHIV-infectedgroup(Fig.S1D,Table1).
3.3 | For HIV- uninfected Malawian women, those 
at parturition have a higher WCC and neutrophil 
count, but lower lymphocyte count, than non- 
pregnant women
We explored the effect of pregnancy at parturition on leukocyte and 
lymphocyte subsets by comparing results between parturient and 
non- pregnant HIV- uninfected Malawian women. Parturient women 
had a higher median WCC than non- pregnant women (P<.001) due 
to a neutrophilia, and approximately half as many lymphocytes as 
non- pregnant women (P<.001)(Table1andFig.S2A).Aspercentages
of total WCC, parturient women had more neutrophils (P=.002) and 
fewer lymphocytes (P=.003) and fewer monocytes (P=.002) than non- 
pregnantwomen(Fig.S2B).Parturientwomenhadsignificantlysmaller
absolute numbers of lymphocyte subsets (total T, CD4+ T, CD8+ T, 
γδ T, B and NK cells) than non- pregnant women (P<.001;Fig.S2C).
In these HIV- uninfected populations, parturient and non- pregnant 
womenhadsimilarlymphocytesubsetproportions(FigS2D,Table1).
3.4 | Among pregnant women at parturition, 
HIV- infected individuals have a lower CD4+ T- cell 
count, and a higher CD8+ T- cell count, than HIV- 
uninfected women
To investigate the effect of HIV infection on pregnancy, we compared 
the cell counts and proportions in pregnant HIV- infected women 
with HIV- uninfected pregnant women. Regardless of their HIV sta-
tus, pregnant women had similar WBC, lymphocyte, monocyte and 
totalT-cellcounts(Figure1A,CandTable1).Aswithnon-pregnant
women, the HIV- infected pregnant women had significantly (P<.001) 
fewer CD4+ T cells and more CD8+ T cells than HIV- uninfected preg-
nant women. A similar picture was observed when these subsets 
weredeterminedasapercentageoftotallymphocytes(Figure1D).
3.5 | For HIV- infected women, pregnant women 
have higher WCC and neutrophil counts, but lower 
lymphocyte counts compared to non- pregnant women
We investigated the impact of pregnancy on Malawian women liv-
ing with HIV, by comparing parturient HIV- infected women with 
non- pregnant HIV- infected women. The effect of pregnancy on leu-
kocyte and lymphocyte subsets was the same in HIV- infected as HIV- 
uninfected women.
HIV- infected pregnant women had significantly (P<.001) higher 
WCC and neutrophil counts, but lower (P=.001) lymphocyte counts 
than non-pregnant HIV-infected women (Table1 and Fig. S3A).
Absolute counts of T cells and T- cell subsets were reduced in HIV- 
infected women, as in HIV- uninfected women, but the reduction was 
less marked and the reduction in CD4+ T cells was not significant. 
Pregnant HIV- infected women continued to have lower CD4+ T cells 
and higher CD8+ T cells than HIV- uninfected women, both as absolute 
and percentage counts. There were no significant differences in CD4+ T 
cells, expressed either as a percentage or as absolute counts, between 
the two groups of HIV- infected women. Overall, when expressed as a 
percentage, there were no differences between the pregnant and non- 
pregnant women for all subsets except for B cells (P=.003)(Fig.S3D).
3.6 | HIV- infected and pregnant women have 
higher WCC and neutrophil counts, but lower 
mean lymphocyte, T- cell, CD4+ T, NK and B- cell 
counts compared to HIV- uninfected and non- 
pregnant women
Finally, to investigate the combined effect of simultaneous preg-
nancy and HIV infection, we compared the absolute cell counts and 
percentages in HIV- infected parturient women with those in HIV- 
uninfected non- pregnant women. HIV- infected pregnant women had 
higher (P<.001) WCC and neutrophil counts, but lower lymphocyte 
countscomparedtoHIV-uninfectednon-pregnantwomen(Fig.S4A,
Table 1). A similar picture was observed when these were presented 
aspercentages(Fig.S4B).WiththeexceptionofCD8+ T- cell counts, 
which did not differ between the two groups, HIV- infected pregnant 
women had lower T cells, CD4+ T, NK and B- cell counts compared 
toHIV-uninfectednon-pregnantwomen(Fig.S4C).Whenpresented
as a percentage, HIV- infected pregnant women had a higher propor-
tion (P=.048) of CD8+ T cells compared to the HIV- uninfected non- 
pregnantwomen(Fig.S4D,Table1).
4  | DISCUSSION
Our study firstly investigated only pregnancy- associated changes in 
WCCs and lymphocyte subsets in HIV- uninfected women and the 
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effect of concurrent HIV infection and pregnancy on those changes. 
Previous studies9–13 had reported inconsistent results on how leu-
kocyte and lymphocyte subsets vary in pregnancy of both HIV- 
uninfected and HIV- infected women in Africa. We observed that 
pregnancy alone, in the absence of HIV infection, was associated with 
a reduction in lymphocytes and T- cell numbers across all subsets and 
with a neutrophilia consistent with what had been observed in some 
studies14–18 but not in others.19–21 This lack of consistence in changes 
in total lymphocytes and subsets in pregnancy found in the differ-
ent studies could be because these cell subsets have previously been 
shown to be affected by other factors apart from pregnancy such as 
location and ethnic group.22
HIV infection is characterized by a reduction in total WCC, neutro-
penia and a particular reduction in CD4+ T cells but an increase in CD8+ 
T cells which is what we also observed in this study. Less well studied 
though is the effect of pregnancy on the leukocytes and lymphocyte 
subsets in HIV- infected women. Contrary to our hypothesis, we found 
that the effect of pregnancy in HIV- infected women was similar to that 
observed in HIV- uninfected women effectively ruling out a possible 
synergistic effect of HIV infection and pregnancy as a possible factor 
for the increased proportion of death from sepsis in HIV- infected preg-
nant women. Similar results were found in a study that recruited HIV- 
infected pregnant women in United States of America which found 
that CD4+ T- cell numbers were higher during pregnancy.23 Similarly, 
a study from Italy, in which pregnant and non- pregnant HIV- infected 
women were recruited and followed, only found that pregnant women 
had elevated CD4+ T- cell counts at the point of recruitment.24 None of 
these two studies included HIV- uninfected controls.
Among the few studies that have investigated leukocyte and lym-
phocyte subsets in pregnancy and HIV infection in the sub- Saharan 
Africa (SSA), one recruited HIV- infected and uninfected Malawian 
pregnant women in the third trimester and post- partum but did not 
include non- pregnant women.25 The study found that CD4+ and CD8+ 
absolute counts were higher post- partum than in pregnancy, while 
CD4+ and CD8+ percentages did not change.25 Recent studies carried 
out in SSA11–13 have also reported that HIV infection has the same 
F IGURE  1 Medians for leukocyte subsets expressed as absolute counts (A) and as percentages (B) and lymphocyte subsets expressed as 
absolute counts (C) and as percentages (D) for HIV- uninfected and pregnant women (blue boxes) and for HIV- infected and parturient women 
(red boxes)
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effect on leukocyte and lymphocyte subsets in pregnancy as it does 
in non- pregnant women and does not seem to act synergistically to 
exacerbate the effect of pregnancy on these cell types. However, our 
study provides additional information because it included comparisons 
between the four different groups, HIV- infected and pregnant, HIV- 
infected non- pregnant, HIV- uninfected pregnant and HIV- uninfected 
non- pregnant and it investigated the variation in more cell types than 
the other previous studies conducted in SSA.11–13,25 It is worth men-
tioning that CD4+ and CD8+ T cells have been observed to be sta-
ble when presented as a percentage of the total lymphocyte counts 
than when they are presented as totals counts19,23 and this is simi-
lar to what we and others have reported before for HIV- uninfected 
children during childhood.26,27 Therefore, percentage CD4+ and CD8+ 
T- cell values may have better application than absolute counts for 
assessing immunodeficiency during pregnancy with an added advan-
tage that they can be more easily and accurately performed on flow 
cytometers.28,29
Thereareseverallimitationstothiswork.Firstly,weonlyexamined
blood from pregnant women at the time of parturition but a longitudi-
nal study tracking changes in individual women throughout pregnancy 
and post- partum9 would provide a more comprehensive understanding 
of immunological changes in pregnancy. Secondly, although we inves-
tigated leukocyte and lymphocyte subset numbers and percentages, 
we did not examine their function and this could be crucial additional 
information. Thirdly, ideal comparison between the two HIV- infected 
groups could have been achieved if they were known to be taking 
similar HAART30 and for the same period. Lastly, although the over- 
aged (7/20) HIV- infected women might not be considered representa-
tive controls for the HIV- infected pregnant group, we had previously 
shown that the different leukocyte and lymphocyte subsets do not 
differ greatly between the ages of 18 years and beyond 60 years.26
5  | CONCLUSION
We have examined the separate and combined effects of pregnancy 
and HIV infection on the cellular compartment of the immune system 
in Malawian women by measuring leukocyte and lymphocyte subsets. 
Although changes are seen that can be attributable to the interaction 
of both factors, our general finding is that the effect of pregnancy is the 
dominant factor for each individual immune parameter, apart from CD4+ 
and CD8+ T- cell counts. Contrary to our initial speculation, pregnancy 
does not appear to exacerbate the CD4+ T- cell lymphopenia of HIV in-
fection, and therefore, simple immunophenotyping, such as that under-
taken in this study, cannot easily explain the high levels of infection and 
mortalityamongpregnantwomeninSSA.Furtherstudiesarerequired
to explore this and will ideally follow longitudinally a cohort of women 
of childbearing age and study cell percentage, numbers and function.
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